RIPE Knowledge Graph
RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1016%2Fj.nmni.2025.101692

https://w3id.org/ripe/ripe-kg/work/10.1016%2Fj.nmni.2025.101692
SubjectPredicateObject
ripekg:publication-details/RIPEA2FDF154C3D3A24A0Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis ripe:concerns ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis
ripekg:registry-evidence/RIPEA2FDF154C3D3A24A0 ripe:concerns ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis
ripekg:research-integrity-assessment/RIPEA2FDF154C3D3A24A0 ripe:assesses ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 ripe:concerns ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis prism:doi 10.1016/j.nmni.2025.101692
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAU19DB2864E6420C10Md Rahaman
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAU22FF1F130D0C465DSushant Sahastrabuddhe
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAU4CAF9FFA42285453Tarun Saluja
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAU52BD62DC4039AAC9Sumyta Rahman
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAUC3A6D3BFB8D63636Hee Kim
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAUD8B6D86AF2F0F461Rejwana Pial
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAUE0650447BA41F174K Saif-Ur-Rahman
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:creator ripekg:author/RIPEAUECF672388CF540E9Iffat Tuly
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis dcterms:title Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1002%2F9781119536604Cochrane handbook for systematic reviews of interventions. Cochrane Handbook for Systematic Reviews of Interventions
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1002%2Fcl2.1229Prioritization and sequential exclusion of articles in systematic reviews
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs10787-021-00839-2Real-world effectiveness of BNT162b2 mRNA vaccine: a metaanalysis of large observational studies
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs15010-021-01664-zWaning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.accpm.2021.100967Why promoting a COVID-19 vaccine booster dose?
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.amepre.2020.06.011Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.biopha.2022.112650Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.eclinm.2021.100734Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.eclinm.2023.102372Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.heliyon.2023.e23246Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccinesa prospective multi-center study
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.jclinepi.2012.09.016Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fj.jinf.2024.106165Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for omicron
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs0140-6736%2821%2901115-6Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs0140-6736%2821%2902046-8Considerations in boosting COVID-19 vaccine immune responses
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs0140-6736%2822%2900094-0Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs0140-6736%2822%2900152-0Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs1473-3099%2823%2900199-8Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs2666-5247%2821%2900267-6Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a metaanalysis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs2666-5247%2822%2900390-1Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1038%2Fd41586-021-02158-6COVID vaccine boosters: the Most important questions
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1038%2Fd41586-021-02532-4COVID vaccine immunity is waning -how much does that matter?
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1038%2Fnrd.2017.243mRNA vaccinesa new era in vaccinology
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1038%2Fs41577-020-00479-7A guide to vaccinology: from basic principles to new developments
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1038%2Fs41577-021-00578-zImmunological mechanisms of vaccineinduced protection against COVID-19 in humans
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1038%2Fs41591-021-01377-8Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1056%2Fnejmoa2034577%2Fsuppl_file%2Fnejmoa2034577_data-sharing.pdfSafety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1056%2Fnejmoa2110345%2Fsuppl_file%2Fnejmoa2110345_data-sharing.pdfSafety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1080%2F14760584.2021.1971522To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1080%2F14760584.2024.2320861Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1080%2F21645515.2021.2007015Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? Hum Vaccines Immunother 2021
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1093%2Fcid%2Fciac345Antibody response of heterologous vs homologous messenger RNA vaccine boosters against the severe acute respiratory syndrome coronavirus 2 omicron variant: interim results from the PRIBIVAC study, a randomized clinical trial
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj.39500.677199.aeGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmj.n71The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1136%2Fbmjopen-2023-079071Evolution of the data and methods in realworld COVID-19 vaccine effectiveness studies on mortality: a scoping review protocol
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1177%2F21501319221089255A meta-analysis on the safety and immunogenicity of Covid-19 vaccines
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1186%2Fs12913-014-0579-0%2Ftables%2F7PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1186%2Fs13643-016-0384-4%2Ffigures%2F6Rayyan-a web and mobile app for systematic reviews
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1186%2Fs40249-022-00977-xImmunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.1371%2Fjournal.pgph.0000032Five steps to solving the vaccine inequity crisis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.22037%2Faaem.v10i1.1582COVID-19 vaccines' protection over time and the need for booster doses; a systematic review
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3389%2Ffimmu.2021.612747%2FpdfOptimize prime/boost vaccine strategies: trained immunity as a new player in the game
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3389%2Ffimmu.2021.714170%2FbibtexEfficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3389%2Ffmicb.2022.927306%2FbibtexA comprehensive review of the protein subunit vaccines against COVID-19
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3390%2Fijerph191710752Comparison of the effectiveness and safety of heterologous booster doses with homologous booster doses for SARS-CoV-2 vaccines: a systematic review and meta-analysis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3390%2Fvaccines10030350%2Fs1Efficacy and effectiveness of SARS-CoV-2 vaccines: a systematic review and meta-analysis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3390%2Fvaccines10050798Immunogenicity and safety of homologous and heterologous prime-boost immunization with COVID-19 vaccine: systematic review and meta-analysis
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3390%2Fvaccines9050467%2Fs1Efficacy and safety of covid-19 vaccines: a systematic review and meta-analysis of randomized clinical trials
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.3390%2Fvaccines9090989%2Fs1Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of different vaccines at phase 3. Vaccines (Basel) 2021
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.4014%2Fjmb.2411.11059A meta-analysis on the immunogenicity of homologous versus heterologous immunization regimens against SARS-CoV-2 beta, Delta, and omicron BA.1 VoCs in healthy adults
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.4103%2Fnpmj.npmj_157_20COVID-19 pandemic: a global health burden. Nigerian Postgraduate
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/10.7150%2Fijbs.73583Humoral and cellular immune responses of COVID-19 vaccines against SARS-Cov-2 omicron variant: a systemic review
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEW0A9BDCD27E741E12COVID-19 vaccines | WHO COVID-19 dashboard
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEW805DFE56CE586C14vacc ines?adgroupsurvey=%7Badgroupsurvey%7D&gclid=CjwKCAjw_o-HBh AsEiwANqYhp_ZinKdR5N3rlvVfpDQU_0xaeUGWru7XUg-RVhFvr LPo1iM19w4lzBoCHzQQAvD_BwE
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEW9B869A6F52E2BCB3WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEWAEB5DB8C4FE9FE6ASafety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEWAFD520A88F3807B1Interim statement on booster doses for COVID-19 vaccination
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEWB61128ABD3EFB171Global COVID-19 vaccination strategy in a changing world: july 2022 update
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEWCEE9F1CD36EE1C88Critical evidence questions for COVID-19 vaccines policy making strategic advisory group of experts (SAGE) on immunization working group on COVID-19 vaccines
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEWF1C614BF17634767COVID-19 cases | WHO COVID-19 dashboard
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEWF24CCF214F8C3F0EWeekly epidemiological update on COVID-19 -1
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEWF52A45C6EA4CFC9AStrategy to achieve global Covid-19 vaccination by mid-2022
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis rdf:type node1
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis rdf:type rdfs:Resource
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis rdf:type owl:Thing
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis rdf:type prov:Entity
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis rdf:type ripe:WorkWork
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis owl:sameAs https://semopenalex.org/work/W7117534294